Related Experiment Video
Updated: May 17, 2026
07:18
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
TSLC1 expression discriminates cutaneous melanomas from dysplastic nevi
Yan You1, Shu Huai Wang, Jin Feng Zhang
1Department of Dermatology, Third Affiliated Hospital dDepartment of Dermatology, First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China.
Melanoma Research
|October 11, 2012
Summary
Loss of tumor suppressor in lung cancer 1 (TSLC1) expression is frequent in cutaneous melanoma. This finding suggests TSLC1 can help diagnose difficult melanoma cases, improving skin cancer detection.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Cutaneous melanoma, a significant cause of skin cancer mortality, presents diagnostic challenges, particularly distinguishing it from dysplastic nevi.
- Aberrant methylation and silencing of tumor suppressor genes are implicated in melanoma development.
- Tumor suppressor in lung cancer 1 (TSLC1) has been identified as a tumor suppressor gene involved in cutaneous melanoma generation.
Purpose of the Study:
- To investigate TSLC1 gene expression in various melanocytic skin lesions.
- To evaluate the potential of TSLC1 as a diagnostic marker for histologically ambiguous melanoma cases.
Main Methods:
- Immunohistochemistry was employed to detect cytoplasmic TSLC1 protein expression.
- Quantitative real-time reverse transcription-PCR and Western blot were used to measure TSLC1 mRNA and protein levels, respectively.
Main Results:
- TSLC1 expression was significantly reduced in cutaneous melanomas (3.6-fold decrease) compared to dysplastic nevi and normal skin.
- TSLC1 mRNA and protein levels were substantially higher in normal skin and dysplastic nevi than in melanomas.
- No significant difference in TSLC1 expression was observed between normal skin and dysplastic nevi.
Conclusions:
- A frequent loss of TSLC1 expression occurs in cutaneous melanoma.
- TSLC1 downregulation serves as a potential diagnostic biomarker for identifying cutaneous melanoma, especially in challenging histological cases.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...